Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Lessin

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
European Journal of Clinical Investigation|January 1, 1994
Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory processB O Ibe, J Kurantsin-Mills, J U Raj, et al.
The New England Journal of Medicine|August 31, 1972
Vascular catheters and thrombogenesisL S Lessin, W M Jensen, G A Kelser, et al.
British Journal of Haematology|August 1, 1992
Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patientsJ Kurantsin-Mills, F A Ofosu, T K Safa, et al.
The Journal of Clinical Investigation|October 1, 1978
Inhibition of erythrocyte sickling in vitro by pyridoxalJ A Kark, M P Kale, P G Tarassoff, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the labelJ Kurantsin-Mills, H M Jacobs, R Siegel, et al.
British Journal of Haematology|July 1, 1994
Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulationJ Kurantsin-Mills, B O Ibe, C L Natta, et al.
Cancer|March 15, 1993
Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II studyB R Greenberg, R D Reynolds, C B Charron, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
European Journal of Clinical Investigation|January 1, 1994
Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory processB O Ibe, J Kurantsin-Mills, J U Raj, et al.
The New England Journal of Medicine|August 31, 1972
Vascular catheters and thrombogenesisL S Lessin, W M Jensen, G A Kelser, et al.
British Journal of Haematology|August 1, 1992
Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patientsJ Kurantsin-Mills, F A Ofosu, T K Safa, et al.
The Journal of Clinical Investigation|October 1, 1978
Inhibition of erythrocyte sickling in vitro by pyridoxalJ A Kark, M P Kale, P G Tarassoff, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the labelJ Kurantsin-Mills, H M Jacobs, R Siegel, et al.
British Journal of Haematology|July 1, 1994
Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulationJ Kurantsin-Mills, B O Ibe, C L Natta, et al.
Cancer|March 15, 1993
Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II studyB R Greenberg, R D Reynolds, C B Charron, et al.
Pageof 5